Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386283077> ?p ?o ?g. }
- W4386283077 endingPage "4343" @default.
- W4386283077 startingPage "4343" @default.
- W4386283077 abstract "Background: Multiple randomized trials have established adjuvant endocrine therapy (ET) and whole breast irradiation (WBI) as the standard approach after breast-conserving surgery (BCS) in early-stage breast cancer. The omission of WBI has been studied in multiple trials and resulted in reduced local control with maintained survival rates and has therefore been adapted as a treatment option in selected patients in several guidelines. Omitting ET instead of WBI might also be a valuable option as both treatments have distinctly different side effect profiles. However, the clinical outcomes of BCS + ET vs. BCS + WBI have not been formally analyzed. Methods: We performed a systematic literature review searching for randomized trials comparing BCS + ET vs. BCS + WBI in low-risk breast cancer patients with publication dates after 2000. We excluded trials using any form of chemotherapy, regional nodal radiation and mastectomy. The meta-analysis was performed using a two-step process. First, we extracted all available published event rates and the effect sizes for overall and breast-cancer-specific survival (OS, BCSS), local (LR) and regional recurrence, disease-free survival, distant metastases-free interval, contralateral breast cancer, second cancer other than breast cancer and mastectomy-free interval as investigated endpoints and compared them in a network meta-analysis. Second, the published individual patient data from the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) publications were used to allow a comparison of OS and BCSS. Results: We identified three studies, including a direct comparison of BCS + ET vs. BCS + WBI (n = 1059) and nine studies randomizing overall 7207 patients additionally to BCS only and BCS + WBI + ET resulting in a four-arm comparison. In the network analysis, LR was significantly lower in the BCS + WBI group in comparison with the BCS + ET group (HR = 0.62; CI-95%: 0.42–0.92; p = 0.019). We did not find any differences in OS (HR = 0.93; CI-95%: 0.53–1.62; p = 0.785) and BCSS (OR = 1.04; CI-95%: 0.45–2.41; p = 0.928). Further, we found a lower distant metastasis-free interval, a higher rate of contralateral breast cancer and a reduced mastectomy-free interval in the BCS + WBI-arm. Using the EBCTCG data, OS and BCSS were not significantly different between BCS + ET and BCS + WBI after 10 years (OS: OR = 0.85; CI-95%: 0.59–1.22; p = 0.369) (BCSS: OR = 0.72; CI-95%: 0.38–1.36; p = 0.305). Conclusion: Evidence from direct and indirect comparison suggests that BCS + WBI might be an equivalent de-escalation strategy to BCS + ET in low-risk breast cancer. Adverse events and quality of life measures have to be further compared between these approaches." @default.
- W4386283077 created "2023-08-31" @default.
- W4386283077 creator A5004434507 @default.
- W4386283077 creator A5014165282 @default.
- W4386283077 creator A5017329335 @default.
- W4386283077 creator A5029041045 @default.
- W4386283077 creator A5050549111 @default.
- W4386283077 creator A5059175252 @default.
- W4386283077 creator A5060729994 @default.
- W4386283077 creator A5063570976 @default.
- W4386283077 creator A5073827670 @default.
- W4386283077 date "2023-08-30" @default.
- W4386283077 modified "2023-09-30" @default.
- W4386283077 title "Whole Breast Irradiation in Comparison to Endocrine Therapy in Early Stage Breast Cancer—A Direct and Network Meta-Analysis of Published Randomized Trials" @default.
- W4386283077 cites W146030364 @default.
- W4386283077 cites W1590666178 @default.
- W4386283077 cites W1880798787 @default.
- W4386283077 cites W1883643540 @default.
- W4386283077 cites W1890169097 @default.
- W4386283077 cites W1965320642 @default.
- W4386283077 cites W1969229373 @default.
- W4386283077 cites W1977708978 @default.
- W4386283077 cites W1982853521 @default.
- W4386283077 cites W1996375113 @default.
- W4386283077 cites W2005501262 @default.
- W4386283077 cites W2014610200 @default.
- W4386283077 cites W2029405072 @default.
- W4386283077 cites W2043468165 @default.
- W4386283077 cites W2044702943 @default.
- W4386283077 cites W2052335770 @default.
- W4386283077 cites W2063669051 @default.
- W4386283077 cites W2083503573 @default.
- W4386283077 cites W2096499183 @default.
- W4386283077 cites W2096649414 @default.
- W4386283077 cites W2100025800 @default.
- W4386283077 cites W2100787775 @default.
- W4386283077 cites W2106006569 @default.
- W4386283077 cites W2109051507 @default.
- W4386283077 cites W2109503059 @default.
- W4386283077 cites W2115776903 @default.
- W4386283077 cites W2118728607 @default.
- W4386283077 cites W2119579521 @default.
- W4386283077 cites W2122428334 @default.
- W4386283077 cites W2128585633 @default.
- W4386283077 cites W2134839096 @default.
- W4386283077 cites W2141647078 @default.
- W4386283077 cites W2145064229 @default.
- W4386283077 cites W2147993322 @default.
- W4386283077 cites W2149455283 @default.
- W4386283077 cites W2152656144 @default.
- W4386283077 cites W2156059498 @default.
- W4386283077 cites W2173270165 @default.
- W4386283077 cites W2214665719 @default.
- W4386283077 cites W2269350776 @default.
- W4386283077 cites W2463282139 @default.
- W4386283077 cites W2464220504 @default.
- W4386283077 cites W2516951838 @default.
- W4386283077 cites W2577994305 @default.
- W4386283077 cites W2598117381 @default.
- W4386283077 cites W2598526121 @default.
- W4386283077 cites W2605134575 @default.
- W4386283077 cites W2658028424 @default.
- W4386283077 cites W2740659413 @default.
- W4386283077 cites W2768733244 @default.
- W4386283077 cites W2787929656 @default.
- W4386283077 cites W2913061582 @default.
- W4386283077 cites W2943896931 @default.
- W4386283077 cites W2952817283 @default.
- W4386283077 cites W2965650173 @default.
- W4386283077 cites W2980243529 @default.
- W4386283077 cites W2992619229 @default.
- W4386283077 cites W2993667428 @default.
- W4386283077 cites W2999658574 @default.
- W4386283077 cites W3015308927 @default.
- W4386283077 cites W3015642374 @default.
- W4386283077 cites W3022548009 @default.
- W4386283077 cites W3027207030 @default.
- W4386283077 cites W3036415919 @default.
- W4386283077 cites W3045897492 @default.
- W4386283077 cites W3049481914 @default.
- W4386283077 cites W3081515379 @default.
- W4386283077 cites W3084904507 @default.
- W4386283077 cites W3121014695 @default.
- W4386283077 cites W3123188501 @default.
- W4386283077 cites W3127720839 @default.
- W4386283077 cites W3129239981 @default.
- W4386283077 cites W3131135744 @default.
- W4386283077 cites W3155084502 @default.
- W4386283077 cites W3155702563 @default.
- W4386283077 cites W3160295180 @default.
- W4386283077 cites W3161127983 @default.
- W4386283077 cites W3164881421 @default.
- W4386283077 cites W3185877851 @default.
- W4386283077 cites W4200311461 @default.
- W4386283077 cites W4224308231 @default.
- W4386283077 cites W4256242665 @default.
- W4386283077 cites W4281624688 @default.
- W4386283077 cites W4283077381 @default.